Jeffrey W. Corbett

1.2k citations

22 papers · 887 indexed · h-index 15

Co-authors: William F. DeGrado Stephen F. Martin James D. Rodgers Ronald M. Klabe Susan Erickson‐Viitanen Soo S. Ko Guillermo A. Morales George L. Trainor
Topics: HIV/AIDS drug development and treatment (7 papers)Quinazolinone synthesis and applications (6 papers)HIV Research and Treatment (5 papers)
Cited by: Organic Chemistry Virology Pharmaceutical Science
Journals: Journal of Biological Chemistry Journal of Medicinal Chemistry Antimicrobial Agents and Chemotherapy
Partner nations: United States China

In The Last Decade

Jeffrey W. Corbett

20 papers receiving 846 citations

Peers

Countries citing papers authored by Jeffrey W. Corbett

Since Specialization

Citations

This map shows the geographic impact of Jeffrey W. Corbett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey W. Corbett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey W. Corbett more than expected).

Fields of papers citing papers by Jeffrey W. Corbett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey W. Corbett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey W. Corbett. The network helps show where Jeffrey W. Corbett may publish in the future.

Co-authorship network of co-authors of Jeffrey W. Corbett

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey W. Corbett. A scholar is included among the top collaborators of Jeffrey W. Corbett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey W. Corbett. Jeffrey W. Corbett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of triazolopyrimidine-based PDE8B inhibitors: Exceptionally ligand-efficient and lipophilic ligand-efficient compounds for the treatment of diabetes 2012 ·Bioorganic & Medicinal Chemistry Letters ·Michael P. DeNinno,Stephen W. Wright,John B. Etienne,(unknown),Benjamin N. Rocke,Jeffrey W. Corbett,Daniel W. Kung,Kenneth J. DiRico,Kim Andrews,(unknown),Janice C. Parker,William P. Esler,(unknown),(unknown),Karen L. Houseknecht,Shawn D. Doran	22
2	Synthesis of Unprotected Carboxy Indazoles via Pd-Catalyzed Carbonylation 2012 ·Synthetic Communications ·Philip Wainwright,(unknown),Clare Vickers,Steven B. Coffey,Leanne M. Buzon,Kenneth J. DiRico,(unknown),(unknown),Chris Limberakis,Kevin D. Freeman‐Cook,Jeffrey W. Corbett	2
3	Structure-guided Inhibitor Design for Human Acetyl-coenzyme A Carboxylase by Interspecies Active Site Conversion 2011 ·Journal of Biological Chemistry ·Francis Rajamohan,Eric S. Marr,Allan R. Reyes,James A. Landro,Marie Anderson,Jeffrey W. Corbett,Kenneth J. DiRico,(unknown),Meihua Tu,F.F. Vajdos	5
4	Review of recent acetyl-CoA carboxylase inhibitor patents: mid-2007 – 2008 2009 ·Expert Opinion on Therapeutic Patents ·Jeffrey W. Corbett	31
5	Inhibitors of Mammalian Acetyl-CoA Carboxylase 2007 ·Recent Advances in Cardiovascular Drug Discovery (Formerly Recent Patents on Cardiovascular Drug Discovery) ·Jeffrey W. Corbett,James D. Harwood	19
6	Design and synthesis of potent amido- and benzyl-substituted cis-3-amino-4-(2-cyanopyrrolidide)pyrrolidinyl DPP-IV inhibitors 2007 ·Bioorganic & Medicinal Chemistry Letters ·Jeffrey W. Corbett,Kenneth J. DiRico,(unknown),Brian P. Boscoe,Shawn D. Doran,(unknown),Xiayang Qiu,Mark Ammirati,Maria A. VanVolkenburg,R. Kirk McPherson,Jeremy C. Parker,Eric Cox	20
7	Heteroatom-linked indanylpyrazines are corticotropin releasing factor type-1 receptor antagonists 2007 ·Bioorganic & Medicinal Chemistry Letters ·Jeffrey W. Corbett,(unknown),(unknown),Robert L. Hoffman,Christopher S. Knauer,Lawrence W. Fitzgerald	32
8	3 Discovery of Second Generation Quinazolinone Non-Nucleoside Reverse Transcriptase Inhibitors of Hiv-1 2002 ·Progress in medicinal chemistry ·Jeffrey W. Corbett,James D. Rodgers	15
9	A Review of Recent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor Research Activity 2002 ·Jeffrey W. Corbett	22
10	Trifluoromethyl-containing 3-alkoxymethyl- and 3-aryloxymethyl-2-pyridinones are potent inhibitors of hIV-1 non-nucleoside reverse transcriptase 2001 ·Bioorganic & Medicinal Chemistry Letters ·Jeffrey W. Corbett,(unknown),(unknown),Beverly C. Cordova,Ronald M. Klabe,James D. Rodgers,Susan Erickson‐Viitanen	13
11	3,3a-Dihydropyrano[4,3,2-de]quinazolin-2(1H)-ones are potent non-nucleoside reverse transcriptase inhibitors 2001 ·Bioorganic & Medicinal Chemistry Letters ·Jeffrey W. Corbett,(unknown),Jay A. Markwalder,Beverly C. Cordova,Ronald M. Klabe,Sena Garber,James D. Rodgers,Susan Erickson‐Viitanen	10
12	Novel 2,2-dioxide-4,4-disubstituted-1,3-H-2,1,3-benzothiadiazines as non-nucleoside reverse transcriptase inhibitors 2000 ·Bioorganic & Medicinal Chemistry Letters ·Jeffrey W. Corbett,(unknown),Soo S. Ko,James D. Rodgers,Beverly C. Cordova,Ronald M. Klabe,Susan Erickson‐Viitanen	13
13	Inhibition of Clinically Relevant Mutant Variants of HIV-1 by Quinazolinone Non-Nucleoside Reverse Transcriptase Inhibitors 2000 ·Journal of Medicinal Chemistry ·Jeffrey W. Corbett,Soo S. Ko,James D. Rodgers,(unknown),Nicholas A. Magnus,Lee T. Bacheler,Sharon Diamond,Susan Jeffrey,Ronald M. Klabe,Beverly C. Cordova,Sena Garber,(unknown),George L. Trainor,Paul Anderson,Susan Erickson‐Viitanen	272
14	Solid-Phase Synthesis of Benzopiperazinones 1998 ·The Journal of Organic Chemistry ·Guillermo A. Morales,Jeffrey W. Corbett,William F. DeGrado	78
15	RECENT PROGRESS IN SOLID PHASE HETEROCYCLE SYNTHESES. A REVIEW 1998 ·Organic Preparations and Procedures International ·Jeffrey W. Corbett	18
16	Solid-phase synthesis of a selective αvβ3 integrin antagonist library 1997 ·Bioorganic & Medicinal Chemistry Letters ·Jeffrey W. Corbett,Nilsa Graciani,Shaker A. Mousa,William F. DeGrado	56
17	Applications of Vinylogous Mannich Reactions. Asymmetric Synthesis of the Heteroyohimboid Alkaloids (-)-Ajmalicine, (+)-19-epi-Ajmalicine, and (-)-Tetrahydroalstonine 1995 ·The Journal of Organic Chemistry ·Stephen F. Martin,(unknown),Jeffrey W. Corbett	50
18	Structure of a chiral intermediate in the synthesis of (+)-19-epiajmalicine 1992 ·Acta Crystallographica Section C Crystal Structure Communications ·Vincent M. Lynch,Jeffrey W. Corbett,Stephen F. Martin,(unknown)	0
19	The Stereochemical Course of Nucleophilic Additions of 2-Trialkylsiloxyfurans to CyclicN-Acyliminium Ions 1992 ·Synthesis ·Stephen F. Martin,Jeffrey W. Corbett	43
20	Structure of a key intermediate in the synthesis of (–)-5-carboxytetrahydroalstonine and (–)-tetrahydroalstonine 1991 ·Acta Crystallographica Section C Crystal Structure Communications ·Vincent M. Lynch,Jeffrey W. Corbett,Stephen F. Martin,(unknown)	0

About Jeffrey W. Corbett

Jeffrey W. Corbett is a scholar working on Virology, Organic Chemistry and Infectious Diseases, having authored 22 papers that have together received 887 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (7 papers), Quinazolinone synthesis and applications (6 papers) and HIV Research and Treatment (5 papers). The work is most often cited by research in Organic Chemistry (609 citations), Virology (97 citations) and Pharmaceutical Science (119 citations). Jeffrey W. Corbett has collaborated with scholars based in United States and China. Frequent co-authors include William F. DeGrado, Stephen F. Martin, James D. Rodgers, Ronald M. Klabe, Susan Erickson‐Viitanen, Soo S. Ko, Guillermo A. Morales, George L. Trainor, Sharon Diamond and Paul Anderson. Their work appears in journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact